171 related articles for article (PubMed ID: 25318749)
1. Suppression of the hERG potassium channel response to premature stimulation by reduction in extracellular potassium concentration.
Melgari D; Du C; El Harchi A; Zhang Y; Hancox JC
Physiol Rep; 2014 Oct; 2(10):. PubMed ID: 25318749
[TBL] [Abstract][Full Text] [Related]
2. Electrophysiological characterization of the modified hERG
Zhang Y; Dempsey CE; Hancox JC
Physiol Rep; 2020 Oct; 8(20):e14568. PubMed ID: 33091232
[TBL] [Abstract][Full Text] [Related]
3. Clemastine, a conventional antihistamine, is a high potency inhibitor of the HERG K+ channel.
Ridley JM; Milnes JT; Hancox JC; Witchel HJ
J Mol Cell Cardiol; 2006 Jan; 40(1):107-18. PubMed ID: 16288909
[TBL] [Abstract][Full Text] [Related]
4. Serine mutation of a conserved threonine in the hERG K
Al-Moubarak E; Zhang Y; Dempsey CE; Zhang H; Harmer SC; Hancox JC
Biochem Biophys Res Commun; 2020 Jun; 526(4):1085-1091. PubMed ID: 32321643
[TBL] [Abstract][Full Text] [Related]
5. Functional and pharmacological characterization of an S5 domain hERG mutation associated with short QT syndrome.
Butler A; Zhang Y; Stuart AG; Dempsey CE; Hancox JC
Heliyon; 2019 Apr; 5(4):e01429. PubMed ID: 31049424
[TBL] [Abstract][Full Text] [Related]
6. Altered gating of HERG potassium channels by cobalt and lanthanum.
Sanchez-Chapula JA; Sanguinetti MC
Pflugers Arch; 2000 Jun; 440(2):264-74. PubMed ID: 10898527
[TBL] [Abstract][Full Text] [Related]
7. Time course and voltage dependence of expressed HERG current compared with native "rapid" delayed rectifier K current during the cardiac ventricular action potential.
Hancox JC; Levi AJ; Witchel HJ
Pflugers Arch; 1998 Nov; 436(6):843-53. PubMed ID: 9799397
[TBL] [Abstract][Full Text] [Related]
8. Ranolazine inhibition of hERG potassium channels: drug-pore interactions and reduced potency against inactivation mutants.
Du C; Zhang Y; El Harchi A; Dempsey CE; Hancox JC
J Mol Cell Cardiol; 2014 Sep; 74(100):220-30. PubMed ID: 24877995
[TBL] [Abstract][Full Text] [Related]
9. Action potential clamp characterization of the S631A hERG mutation associated with short QT syndrome.
Butler A; Zhang Y; Stuart AG; Dempsey CE; Hancox JC
Physiol Rep; 2018 Sep; 6(17):e13845. PubMed ID: 30175559
[TBL] [Abstract][Full Text] [Related]
10. Identification through action potential clamp of proarrhythmic consequences of the short QT syndrome T618I hERG 'hotspot' mutation.
Du C; Zhang H; Harmer SC; Hancox JC
Biochem Biophys Res Commun; 2022 Mar; 596():49-55. PubMed ID: 35114584
[TBL] [Abstract][Full Text] [Related]
11. Interactions between amiodarone and the hERG potassium channel pore determined with mutagenesis and in silico docking.
Zhang Y; Colenso CK; El Harchi A; Cheng H; Witchel HJ; Dempsey CE; Hancox JC
Biochem Pharmacol; 2016 Aug; 113():24-35. PubMed ID: 27256139
[TBL] [Abstract][Full Text] [Related]
12. The Susceptibilities of Human Ether-à-Go-Go-Related Gene Channel with the G487R Mutation to Arrhythmogenic Factors.
Hisajima N; Hata Y; Kinoshita K; Fukushima T; Nishida N; Kano M; Tabata T
Biol Pharm Bull; 2015; 38(5):781-4. PubMed ID: 25947924
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the current of heterologously expressed HERG potassium channels by imipramine and amitriptyline.
Teschemacher AG; Seward EP; Hancox JC; Witchel HJ
Br J Pharmacol; 1999 Sep; 128(2):479-85. PubMed ID: 10510461
[TBL] [Abstract][Full Text] [Related]
14. Febrile temperature facilitates hERG/IKr degradation through an altered K(+) dependence.
Zhao Y; Wang T; Guo J; Yang T; Li W; Koichopolos J; Lamothe SM; Kang Y; Ma A; Zhang S
Heart Rhythm; 2016 Oct; 13(10):2004-11. PubMed ID: 27321242
[TBL] [Abstract][Full Text] [Related]
15. New aspects of HERG K⁺ channel function depending upon cardiac spatial heterogeneity.
Zhang P; Guan P; Bai XL; Song ZP
PLoS One; 2014; 9(1):e72181. PubMed ID: 24475014
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the hERG Potassium Channel by a Methanesulphonate-Free E-4031 Analogue.
Helliwell MV; Zhang Y; El Harchi A; Dempsey CE; Hancox JC
Pharmaceuticals (Basel); 2023 Aug; 16(9):. PubMed ID: 37765012
[No Abstract] [Full Text] [Related]
17. Rapid kinetic interactions of ranolazine with HERG K+ current.
Rajamani S; Shryock JC; Belardinelli L
J Cardiovasc Pharmacol; 2008 Jun; 51(6):581-9. PubMed ID: 18520952
[TBL] [Abstract][Full Text] [Related]
18. Blockade of the Human Ether A-Go-Go-Related Gene (hERG) Potassium Channel by Fentanyl.
Tschirhart JN; Li W; Guo J; Zhang S
Mol Pharmacol; 2019 Apr; 95(4):386-397. PubMed ID: 30665971
[TBL] [Abstract][Full Text] [Related]
19. Impact of the whole-cell patch-clamp configuration on the pharmacological assessment of the hERG channel: trazodone as a case example.
Rodriguez-Menchaca AA; Ferrer T; Navarro-Polanco RA; Sanchez-Chapula JA; Moreno-Galindo EG
J Pharmacol Toxicol Methods; 2014; 69(3):237-44. PubMed ID: 24412489
[TBL] [Abstract][Full Text] [Related]
20. Modification by KCNE1 variants of the hERG potassium channel response to premature stimulation and to pharmacological inhibition.
Du C; El Harchi A; Zhang H; Hancox JC
Physiol Rep; 2013 Nov; 1(6):e00175. PubMed ID: 24400172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
